Jackie Fairley has more than 25 years of operational experience in the pharmaceutical and biotechnology industries with companies including CSL and Faulding (now Hospira/Pfizer) and most recently as CEO of ASX listed Starpharma Holdings (SPH). Under her leadership the Company has advanced into ASX300, attracted significant new investment from global funds and developed several new and valuable commercial products based on Starpharma’s proprietary polymer technology.